MedPath

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHYAGOKSHURADI KWATHA AND SHATAVARYADI KWATHA IN PITTAJA MUTRAKRICCHRA

Phase 2
Conditions
Health Condition 1: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2021/11/037733
Lead Sponsor
MURALIDHAR A MIRAJKAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient within the age group of 16-60 years, who will give their written consent, who will agree to follow the protocol of study. Patients with classical symptoms of pittaja mutrakricchra like peeta mutrata, sarakta mutrata, daaha mutrata, rujayukta mutrata and muhur mutrata.

Exclusion Criteria

Paittika mutrakricchra caused due to marmabhighata, due to congenital deformity, due to STD. Vulnerable groups like pregnant women, lactating mother. Patients with other systemic disorders like diabetes mellitus, thyroid disorders, cardiac illness and other disorders which interfere with the treatment. Secondary to disorders like Asthma, BPH, acute renal failure, vesico-ureteric reflux, tumor, renal tuberculosis. Patients who are not willing to consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
THE EFFECT OF THE TREATMENT WILL BE ASSESSED BASED ON DETAILED CASE PROFORMA ADOPTING STANDARD SCORING METHODS OF SUBJECTIVE PARAMETERS SUCH AS PAINFUL MICTURITION BURNING MICTURITION DIFFICULTY IN MICTURITION FREQUENCY OF MICTURITION NOCTURIA AND OBJECTIVE PARAMETERS SUCH AS YELLOW COLORATION OF URINE HEMATURIA PUS CELLS/HPF EPITHELIAL CELLS/HPF RBCS/HPF. PRE AND POST INTERVENTIONAL ASSESSMENT WILL BE DONE.Timepoint: AT BASELINE 4TH DAY 8TH DAY AND 15TH DAY
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath